Paul G Thomas Selected Research

Paul G Thomas Research Topics

Disease

78	Infections 04/2024 - 04/2005
48	Human Influenza (Influenza) 11/2023 - 01/2006
27	Neoplasms (Cancer) 03/2024 - 12/2010
18	COVID-19 11/2023 - 05/2020
13	Inflammation (Inflammations) 01/2023 - 07/2013
11	Virus Diseases (Viral Diseases) 07/2023 - 05/2013
7	Pneumonia (Pneumonitis) 04/2024 - 09/2014
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 01/2019
4	Cytokine Release Syndrome 07/2023 - 01/2017
3	Neuroblastoma 03/2024 - 11/2021
3	Coinfection 01/2023 - 03/2014
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2017
2	Glioma (Gliomas) 12/2023 - 06/2023
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 12/2022
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2022 - 01/2019
2	Breakthrough Infections 01/2022 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2022 - 10/2016
2	Residual Neoplasm 01/2021 - 01/2019
2	Leukemia 01/2020 - 01/2015
2	Persistent Infection 12/2018 - 06/2017
2	Communicable Diseases (Infectious Diseases) 12/2018 - 01/2016
2	Lung Injury 01/2018 - 01/2016
2	Respiratory Syncytial Virus Infections 12/2011 - 02/2011
1	Obesity 04/2024
1	Herpes Zoster 04/2024
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 03/2024
1	Viremia 03/2024
1	Carcinoma (Carcinomatosis) 03/2024
1	Brain Neoplasms (Brain Tumor) 12/2023
1	Encephalitis (Encephalitis, Rasmussen) 11/2023
1	Post-Acute COVID-19 Syndrome 07/2023
1	COVID-19 related pediatric multisystem inflammatory disease 07/2023
1	Multiple Organ Failure (MODS) 01/2023
1	Chronic Disease (Chronic Diseases) 01/2023

Drug/Important Bio-Agent (IBA)

22	EpitopesIBA 04/2024 - 03/2007
22	CytokinesIBA 10/2023 - 03/2007
21	AntigensIBA 03/2024 - 02/2009
20	VaccinesIBA 11/2023 - 04/2005
14	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2006
13	Antiviral Agents (Antivirals)IBA 04/2024 - 01/2013
11	AntibodiesIBA 11/2023 - 01/2014
8	Immunoglobulin G (IgG)IBA 11/2023 - 01/2021
8	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 02/2011
7	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2013
7	EnzymesIBA 11/2023 - 01/2014
7	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2014
7	Peptides (Polypeptides)IBA 11/2021 - 01/2006
6	ImmunosorbentsIBA 11/2023 - 01/2014
6	InterferonsIBA 01/2023 - 04/2006
6	ChemokinesIBA 01/2022 - 03/2009
5	Immunoglobulin A (IgA)IBA 10/2023 - 01/2014
5	Messenger RNA (mRNA)IBA 01/2023 - 09/2021
5	deoxythymidine 3',5'-bis-(p-nitrophenyl phosphate)IBA 10/2015 - 03/2007
4	Influenza Vaccines (Influenza Vaccine)FDA Link 04/2024 - 12/2010
4	Immune Checkpoint InhibitorsIBA 12/2023 - 12/2016
4	Chimeric Antigen ReceptorsIBA 12/2023 - 11/2022
4	Interleukin-6 (Interleukin 6)IBA 12/2020 - 01/2016
3	COVID-19 VaccinesIBA 11/2023 - 01/2022
3	Neutralizing AntibodiesIBA 11/2023 - 01/2016
3	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021 - 12/2020
3	Amino Acids FDA Link 11/2021 - 01/2013
3	Oseltamivir (Tamiflu)FDA Link 12/2019 - 01/2015
3	Histones (Histone)IBA 12/2019 - 11/2014
2	Glycoproteins (Glycoprotein)IBA 04/2024 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 04/2024 - 05/2013
2	Adrenergic Agents (Adrenergic Drugs)IBA 03/2024 - 03/2024
2	N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA 03/2024 - 11/2021
2	HLA-A Antigens (HLA-A)IBA 11/2023 - 01/2018
2	Interleukin-8 (Interleukin 8)IBA 10/2023 - 01/2017
2	Interleukin-10 (Interleukin 10)IBA 10/2023 - 01/2017
2	Interleukin-18 (Interleukin 18)IBA 10/2023 - 01/2023
2	Indicators and Reagents (Reagents)IBA 12/2022 - 07/2008
2	Neoplasm Antigens (Tumor Antigens)IBA 10/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2020
2	mRNA VaccinesIBA 01/2022 - 01/2022
2	Monoclonal AntibodiesIBA 09/2021 - 07/2008
2	Viral AntigensIBA 01/2021 - 11/2014
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2020 - 05/2020
2	Peptide Hydrolases (Proteases)FDA Link 11/2020 - 02/2014
2	Histocompatibility Antigens Class IIBA 10/2020 - 12/2010
2	Interferon-gamma (Interferon, gamma)IBA 05/2020 - 12/2014
2	NucleoproteinsIBA 01/2019 - 01/2013
2	AcidsIBA 01/2019 - 01/2013
2	Phospholipase DIBA 05/2017 - 09/2014
2	LipidsIBA 05/2017 - 07/2013
2	1-dodecylpyridoxal (PLD)IBA 12/2014 - 09/2014
2	Phosphotransferases (Kinase)IBA 12/2013 - 05/2013
1	LeptinIBA 04/2024
1	AdiponectinIBA 04/2024
1	Histone DemethylasesIBA 03/2024
1	Protein Kinase C-deltaIBA 12/2023
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2023
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	S100A12 ProteinIBA 01/2023

Therapy/Procedure

18	Therapeutics 04/2024 - 03/2014
13	Immunotherapy 03/2024 - 01/2016
4	Drug Therapy (Chemotherapy) 03/2024 - 10/2016
3	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2024 - 12/2022
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2024